Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer
Kathleen E. Houlahan1,2,3, Amirali Salmasi4, Taylor Y. Sadun4, Aydin Pooli4, Ely R. Felker5, Julie Livingstone1, Vincent Huang1, Steven S. Raman5, Preeti Ahuja5, Anthony E. Sisk6, Paul C. Boutros1,2,3,4,7,8,9,10,11, Robert E. Reiter4,9,12,13
1Ontario Institute for Cancer Research, Toronto, Canada
2Department of Medical Biophysics, University of Toronto, Toronto, Canada
3Vector Institute, Toronto, Canada
4Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
5Department of Radiology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
6Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
7Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada
8Department of Human Genetics, University of California, Los Angeles, CA, USA
9Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
10Institute for Precision Health, University of California, Los Angeles, CA, USA
11UCLA Department of Human Genetics, 10833 Le Conte Avenue, Los Angeles, CA 90095
12Institute of Urologic Oncology, University of California, Los Angeles, CA, USA
13Department of Urology, David Geffen School of Medicine, 300 Stein Plaza, Los Angeles, CA 90095, USA
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
European Urology
Tập 76
18-23
Thông tin tác giả